Bone Abstracts

Non-unions and critical size defects (CSD) are major orthopedic challenges. The gold standard for CSD treatment, bone grafting, is associated with several morbidities. Growth factors such as bone morphogenetic proteins (BMPs) have been utilized in clinic. Nevertheless, huge doses are required for therapeutic effects. Endogenous BMP antagonists, such as Noggin, could be inhibited using small interfering RNA (siRNA) to increase the bioavailability of BMPs and accelerate bone hea...